179 related articles for article (PubMed ID: 28004999)
1. A Follow-Up Study on the Renal Protective Efficacy of Telbivudine for Hepatitis B Virus-Infected Taiwanese Patients After Living Donor Liver Transplant.
Lin KH; Chen YL; Lin PY; Hsieh CE; Ko CJ; Lin CC; Ming YZ
Exp Clin Transplant; 2017 Feb; 15(1):65-68. PubMed ID: 28004999
[TBL] [Abstract][Full Text] [Related]
2. Telbivudine in liver transplant recipients: Renal protection does not overcome the risk of polyneuropathy and myopathy.
Turan I; Yapali S; Bademkiran F; Kose T; Duman S; Sozbilen M; Gunsar F; Ersoz G; Akarca US; Ozutemiz O; Karasu Z
Liver Transpl; 2015 Aug; 21(8):1066-75. PubMed ID: 25845464
[TBL] [Abstract][Full Text] [Related]
3. Comparison of efficacy and renal safety of telbivudine and entecavir in treatment-naive elderly patients with chronic hepatitis B.
Law ST; Lee MK; Li KK; Mok CK
Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):193-8. PubMed ID: 26587867
[TBL] [Abstract][Full Text] [Related]
4. Comparison of clinical efficacy and renal safety of telbivudine and entecavir in chronic hepatitis B patients receiving cytotoxic chemotherapy.
Law ST; Lee MK; Lee AS; Tung Y; Li KK
J Dig Dis; 2016 May; 17(5):325-33. PubMed ID: 27085094
[TBL] [Abstract][Full Text] [Related]
5. A comparison of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive patients: a prospective cohort study in China.
Zhang Y; Hu P; Qi X; Ren H; Mao RC; Zhang JM
Clin Microbiol Infect; 2016 Mar; 22(3):287.e1-9. PubMed ID: 26548508
[TBL] [Abstract][Full Text] [Related]
6. Outcome of Hepatitis B Virus Infection After Living-Donor Liver Transplant: A Single-center Experience Over 20 Years.
Nafady-Hego H; Elgendy H; Nafady A; Uemoto S
Exp Clin Transplant; 2016 Apr; 14(2):207-14. PubMed ID: 26867537
[TBL] [Abstract][Full Text] [Related]
7. Telbivudine versus entecavir in patients with undetectable hepatitis B virus DNA: a randomized trial.
An J; Lim YS; Kim GA; Han SB; Jeong W; Lee D; Shim JH; Lee HC; Lee YS
BMC Gastroenterol; 2017 Jan; 17(1):15. PubMed ID: 28103819
[TBL] [Abstract][Full Text] [Related]
8. Telbivudine is associated with improvement of renal function in patients transplanted for HBV liver disease.
Cholongitas E; Vasiliadis T; Goulis I; Fouzas I; Antoniadis N; Papanikolaou V; Akriviadis E
J Viral Hepat; 2015 Jul; 22(7):574-80. PubMed ID: 25385239
[TBL] [Abstract][Full Text] [Related]
9. Comparison of renal safety and efficacy of telbivudine, entecavir and tenofovir treatment in chronic hepatitis B patients: real world experience.
Tsai MC; Chen CH; Tseng PL; Hung CH; Chiu KW; Wang JH; Lu SN; Lee CM; Chang KC; Yen YH; Lin MT; Chou YP; Hu TH
Clin Microbiol Infect; 2016 Jan; 22(1):95.e1-95.e7. PubMed ID: 26055419
[TBL] [Abstract][Full Text] [Related]
10. Telbivudine improves renal function in patients with chronic hepatitis B.
Gane EJ; Deray G; Liaw YF; Lim SG; Lai CL; Rasenack J; Wang Y; Papatheodoridis G; Di Bisceglie A; Buti M; Samuel D; Uddin A; Bosset S; Trylesinski A
Gastroenterology; 2014 Jan; 146(1):138-146.e5. PubMed ID: 24067879
[TBL] [Abstract][Full Text] [Related]
11. A comparison of efficacy and safety of 2-year telbivudine and entecavir treatment in patients with chronic hepatitis B: a match-control study.
Tsai MC; Chen CH; Hung CH; Lee CM; Chiu KW; Wang JH; Lu SN; Tseng PL; Chang KC; Yen YH; Hu TH
Clin Microbiol Infect; 2014 Feb; 20(2):O90-O100. PubMed ID: 23659493
[TBL] [Abstract][Full Text] [Related]
12. A new scheme with infusion of hepatitis B immunoglobulin combined with entecavir for prophylaxis of hepatitis B virus recurrence among liver transplant recipients.
Chen G; Liu H; Hu ZQ; Bai JH; Liu QY; Zhao YP; Gan XM; Wang F; Wang DD; Ma LJ; Li L
Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):901-6. PubMed ID: 26011237
[TBL] [Abstract][Full Text] [Related]
13. Use of telbivudine in kidney transplant recipients with chronic hepatitis B virus infection: A preliminary experience.
Yap DY; Chan TM
Nephrology (Carlton); 2016 May; 21(5):438-41. PubMed ID: 26484932
[TBL] [Abstract][Full Text] [Related]
14. Effects of entecavir, tenofovir and telbivudine treatment on renal functions in chronic hepatitis B patients.
Kara AV; Yıldırım Y; Ozcicek F; Aldemir MN; Arslan Y; Bayan K; Çelen MK
Acta Gastroenterol Belg; 2019; 82(2):273-277. PubMed ID: 31314188
[TBL] [Abstract][Full Text] [Related]
15. Successful Management of De Novo Acute Hepatitis B Virus Infection With Entecavir in a Living-Donor Liver Transplant Patient.
Akbulut S; Harputluoglu M; Yilmaz S
Exp Clin Transplant; 2018 Oct; 16(5):635-637. PubMed ID: 29790455
[TBL] [Abstract][Full Text] [Related]
16. Comparison of telbivudine and entecavir on the change of off- treatment eGFR after 3 years of treatment in non-cirrhotic chronic hepatitis B patients.
Lin YS; Shih SC; Wang HY; Lin CC; Chang CW; Chen MJ
BMC Gastroenterol; 2017 Jan; 17(1):22. PubMed ID: 28137301
[TBL] [Abstract][Full Text] [Related]
17. Forty-eight-week retrospective study of telbivudine and lamivudine treatment in patients with hepatitis B-related cirrhosis.
Han Z; Shi Y; Zhu J; Chen Y; Yin F; Xia L; Luo G; Gao Z; Liu J; Jia G; Li C; Zhou X; Han Y
J Viral Hepat; 2013 Apr; 20 Suppl 1():58-64. PubMed ID: 23458526
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of telbivudine compared with entecavir in hepatitis B virus-related cirrhosis: 2 year follow-up data.
Kim HR; Yim HJ; Kang S; Suh SJ; Kim SY; Hyun JJ; Koo JS; Kim JH; Seo YS; Yeon JE; Lee SW; Byun KS; Um SH
Liver Int; 2015 Mar; 35(3):860-9. PubMed ID: 24905912
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Telbivudine and Entecavir Therapy on Nephritic Function and Drug Resistance in Patients with Hepatitis B Virus-Related Compensated Cirrhosis.
Shen H; Ding F; Wang Z; Sun F; Yu Y; Zhou J; Xu W; Ni J; Wang J; Yang Y
Cell Physiol Biochem; 2016; 40(1-2):370-378. PubMed ID: 27866195
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in prevention of hepatitis B recurrence after liver transplantation.
Xi ZF; Xia Q
World J Gastroenterol; 2015 Jan; 21(3):829-35. PubMed ID: 25624716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
